BioStock article: Positive results from Aptahem`s collaboration with Örebro University
(WorldNews Sweden)

BioStock published an article on 1 July 2020 about Aptahem, which can be read in full below. At the end of last year, Aptahem entered a consortium with Örebro University with the aim of evaluating new strategies to reduce inflammation, thrombosis and fibrosis in cardiovascular disease. Yesterday, the company was able to announce the first preliminary data from the project and these confirmed the anti-inflammatory and non-toxic properties of Aptahem`s drug candidate Apta-1. In addition, the data also indicated that the candidate may have a positive effect on inflammation in blood vessels. Biotech Aptahem develops Apta-1 as an emergency drug for sepsis, a very serious condition that affects...